HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antti Pertovaara Selected Research

Carbenoxolone

4/2021Spinal mechanisms contributing to the development of pain hypersensitivity induced by sphingolipids in the rat.
11/2016Mechanical antihypersensitivity effect induced by repeated spinal administrations of a TRPA1 antagonist or a gap junction decoupler in peripheral neuropathy.
12/2010Intrathecal administration of a gap junction decoupler, an inhibitor of Na(+)-K(+)-2Cl(-) cotransporter 1, or a GABA(A) receptor agonist attenuates mechanical pain hypersensitivity induced by REM sleep deprivation in the rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Antti Pertovaara Research Topics

Disease

64Pain (Aches)
06/2022 - 09/2002
32Hypersensitivity (Allergy)
06/2022 - 01/2004
16Hyperalgesia
01/2020 - 05/2002
13Neuralgia (Stump Neuralgia)
01/2022 - 01/2004
6Chronic Pain
01/2022 - 10/2004
6Peripheral Nervous System Diseases (PNS Diseases)
12/2014 - 06/2007
6Sleep Deprivation
10/2013 - 05/2007
5Inflammation (Inflammations)
11/2016 - 01/2003
4Peripheral Nerve Injuries
02/2019 - 05/2007
4Diabetes Mellitus
01/2017 - 07/2009
4Facial Pain (Myofacial Pain)
11/2016 - 10/2004
3Diabetic Neuropathies (Diabetic Neuropathy)
07/2013 - 01/2012
3Neurogenic Inflammation
09/2011 - 08/2010
2Parkinson Disease (Parkinson's Disease)
01/2020 - 07/2008
2Arthritis (Polyarthritis)
10/2013 - 07/2007
1Colorectal Neoplasms (Colorectal Cancer)
06/2022
1Musculoskeletal Pain
09/2018
1Myalgia
01/2017
1Sleep Wake Disorders
11/2016

Drug/Important Bio-Agent (IBA)

11TRPA1 Cation ChannelIBA
11/2016 - 07/2009
9salicylhydroxamic acid (SHAM)IBA
01/2018 - 02/2003
8Dopamine (Intropin)FDA LinkGeneric
09/2018 - 09/2004
8Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
10/2014 - 09/2002
8Ion Channels (Ion Channel)IBA
10/2013 - 07/2009
7Analgesics (Analgesic Drugs)IBA
06/2022 - 06/2009
7Pharmaceutical PreparationsIBA
11/2016 - 10/2010
6AnkyrinsIBA
11/2018 - 03/2011
6Adrenergic Receptors (Adrenergic Receptor)IBA
12/2014 - 01/2003
5Serotonin (5 Hydroxytryptamine)IBA
09/2018 - 06/2007
5Capsaicin (Zostrix)FDA Link
01/2017 - 07/2004
5atipamezoleIBA
02/2013 - 01/2005
4N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
04/2021 - 05/2007
4Minocycline (Cyclops)FDA LinkGeneric
02/2019 - 12/2010
4Glutamic Acid (Glutamate)FDA Link
01/2015 - 08/2011
4radolmidineIBA
02/2013 - 01/2003
45-HT1A Serotonin ReceptorIBA
07/2009 - 03/2006
3CarbenoxoloneIBA
04/2021 - 12/2010
3Morphine (MS Contin)FDA LinkGeneric
01/2020 - 02/2003
3N-Methylaspartate (NMDA)IBA
02/2016 - 07/2008
3Dimenhydrinate (DMH)FDA LinkGeneric
01/2015 - 10/2013
3Reactive Oxygen Species (Oxygen Radicals)IBA
01/2014 - 04/2011
3Norepinephrine (Noradrenaline)FDA LinkGeneric
09/2013 - 10/2006
36-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA
03/2013 - 05/2004
3Streptozocin (Streptozotocin)FDA Link
03/2013 - 07/2009
2ML 204IBA
06/2022 - 11/2015
2Dizocilpine Maleate (Dizocilpine)IBA
04/2021 - 02/2019
2D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA
04/2021 - 10/2013
2CationsIBA
11/2018 - 07/2013
2CalciumIBA
11/2018 - 07/2013
2cinnamaldehyde (cinnamic aldehyde)FDA Link
11/2016 - 01/2014
2Histamine H3 Receptors (Histamine H3 Receptor)IBA
02/2016 - 12/2014
2Histamine (Histamine Dihydrochloride)FDA Link
02/2016 - 12/2014
2A-960656IBA
02/2016 - 12/2014
2Lidocaine (Xylocaine)FDA LinkGeneric
01/2015 - 10/2013
2GalaninIBA
01/2015 - 01/2014
2CarrageenanIBA
04/2014 - 05/2003
2Pyruvaldehyde (Methylglyoxal)IBA
01/2014 - 07/2013
24-hydroxy-2-nonenal (4-hydroxynonenal)IBA
01/2014 - 07/2013
2PlasticsIBA
09/2013 - 10/2006
2Adrenergic Agents (Adrenergic Drugs)IBA
09/2013 - 05/2003
2Opioid Receptors (Opioid Receptor)IBA
07/2012 - 07/2007
2MuscimolIBA
12/2010 - 05/2009
2GABA-A Receptor AgonistsIBA
12/2010 - 05/2009
2Pentobarbital (Nembutal)FDA Link
06/2010 - 03/2009
2QuinpiroleIBA
05/2009 - 06/2007
2RacloprideIBA
05/2009 - 03/2005
2Serotonin ReceptorsIBA
06/2008 - 06/2007
1HC-070IBA
06/2022
1Pregabalin (Lyrica)FDA Link
06/2022
1Netrin-1IBA
06/2022
1Chemotactic FactorsIBA
06/2022
1Designer DrugsIBA
01/2022
1CytokinesIBA
04/2021
1N- (2- (3,4- Dichlorphenyl)ethyl)- N,N',N'- trimethyl- 1,2- ethandiaminIBA
04/2021
1PregnenoloneIBA
04/2021
15-methylpyrazole-3-carboxylic acidIBA
04/2021
1SphingolipidsIBA
04/2021
1naringeninIBA
04/2021
1N,N-dimethylsphingosineIBA
04/2021
1isosakuranetinIBA
04/2021
1A-317491IBA
01/2020
1Therapeutic UsesIBA
01/2020
1KetamineFDA LinkGeneric
01/2020
1Oxidopamine (6 Hydroxydopamine)IBA
01/2020
1Purinergic P2X3 ReceptorsIBA
01/2020
1Oxycodone (Oxycontin)FDA LinkGeneric
01/2020
1tetrapentylammonium (tetrapentylammonium chloride)IBA
02/2019
1Neurotransmitter Agents (Neurotransmitter)IBA
09/2018
15-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
09/2018
1Biological ProductsIBA
07/2018
1Acetaminophen (Paracetamol)FDA LinkGeneric
01/2018
1AcetoneIBA
01/2017
1Gabapentin (Neurontin)FDA LinkGeneric
11/2016

Therapy/Procedure

10Ligation
02/2016 - 05/2002
4Analgesia
01/2022 - 03/2005
3Therapeutics
11/2018 - 09/2011
3Transcranial Magnetic Stimulation
11/2016 - 10/2014
3Catheters
12/2014 - 12/2010
2Lasers (Laser)
08/2010 - 03/2006
1Acupuncture Points (Acupuncture Point)
01/2017